Navigation Links
Embargoed study: New quality, payment initiative positively impacts pediatric care
Date:12/22/2013

BOSTON (Dec. 23, 2013)Within two years of implementation, Blue Cross Blue Shield of Massachusetts' Alternative Quality Contract (AQC) had a small but significant positive effect on the quality of pediatric care, according to a new study from Boston Children's Hospital. The results were published online Dec. 23 in Pediatrics.

To stem the continued growth in health care spending, Blue Cross Blue Shield of Massachusettsthe state's largest commercial payerimplemented an AQC in 2009. A prototypical arrangement, the AQC offers providers a baseline budget to cover the continuum of care, while also awarding pay-for-performance bonuses for improved care quality metrics. This AQC was unique for including pediatric quality measures in its contract.

"Because the size and spending levels of the adult population are so much greater than for kids, how large health care contracts affect pediatric patients is often treated as an afterthought," says the study's lead author Alyna Chien, MD, from Boston Children's Division of General Pediatrics. "But children, especially those with chronic or severe medical conditions, can contribute significantly to health care costs. If spending is to be contained, it's important to understand the impact of the AQC on children as well as adults."

Researchers compared the quality and cost of care provided to 126,975 cases within the AQC structure against 415,331 similar patients who were not in the AQC, across a study period from 2006 to 2010. Quality measures tied to pay-for-performance rates of preventive/screening care and acute care were analyzed, as was care of asthma and attention deficit disorder, which were not directly tied to bonuses.

"We examined whether the AQC affected asthma and ADHD care in an unintended fashion, since they are the two most common chronic conditions of childhood," says Chien. "A better understanding of the effect of the AQC on their care and cost could provide much nee
'/>"/>

Contact: meghan weber
meghan.weber@childrens.harvard.edu
617-919-3656
Boston Children's Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds
2. Embargoed news from Annals of Internal Medicine
3. World Health Organization study: Atrial fibrillation is a growing global health concern
4. Vanderbilt study: Ancient chemical bond may aid cancer therapy
5. Study: Majority of epilepsy surgery patients enjoy improvement in their physical and social well-being
6. ADHD study: Expensive training programs dont help kids grades, behavior
7. Study: Ureteral injury during robot-assisted prostate surgery
8. Study: Odds of rehospitalization of cognitively impaired varies by discharge destination
9. Mayo Clinic-led study: 2 drugs do not improve kidney function in acute heart failure patients
10. Regenstrief and IU study: Older adults with severe mental illness challenge healthcare system
11. Princeton study: Military children and their families remain an invisible subculture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 28, 2015 , ... Dr. Robert G. Schwartz ... practice has teamed up with Realief Neuropathy Centers in order to offer his patients ... the signs and symptoms of peripheral neuropathy. , Peripheral neuropathy is a disease caused ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, ... brain volumes that may be early indicators of Alzheimer’s disease and dementia, according ... that vascular risk factors damage the brain and can result in cognitive impairment,” ...
(Date:7/27/2015)... Madre, CA (PRWEB) , ... July 27, 2015 ... ... of healthcare today, especially in wound center management. Earlier this year Wound ... wound care education and training for WCA wound centers. Customized learning paths ...
(Date:7/27/2015)... Los Angeles, CA (PRWEB) , ... July 27, 2015 , ... ... See the Derm for 7 Common Skin Issues,” describes common skin issues such as ... the technology available for cosmetic dermatologists to treat them. The treatment options listed include ...
(Date:7/27/2015)... ... July 27, 2015 , ... Send ... and mobile collaboration, announced today the latest software release for ... and other feature enhancements. , This software release gives the widely used online ...
Breaking Medicine News(10 mins):Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:The Latest Treatment Options for Seven Common Skin Issues 2Health News:Send Word Now Announces Release of New User Interface for its Award-Winning Mass Notification Service 2
... a key molecule that controls the growth, spread and survival ... toward new and better treatment options for pancreatic cancer . ... Beta molecule plays in pancreatic cancer and that they have ... and survival through its effect on NF Kappa B -- ...
... the drug alendronate (Fosamax) can reduce the risk of vertebral ... not osteoporosis. 3,737 postmenopausal women between ages 55 and 80 ... -2.5 were evaluated . About half the women randomly received ... thereafter while the other half took a placebo. ,The ...
... its growth factors aren’t just produced in the pancreas, but ... areas of the brain//, the result can be brain cell ... people with Alzheimer’s. ,The research was conducted in rats, ... IGF I and IGF II were produced in the nerve ...
... well known that HIV patients are at an increased risk ... study shows // aggressive antiretroviral therapy may help lower that ... antiretroviral therapy was associated with a lower incidence of Kaposi ... on more than 7,300 patients infected with HIV and the ...
... Intravenous administration of the drug tezosentan did not improve worsening ... failure // despite high hopes. The above fact was found ... to date. The study was conducted to evaluate if something ... order to speed up hospital discharge and prevent them from ...
... that how much we drink may be decided by a ... gene called DRD2 Taq1A(C32806T) polymorphism and social alcohol drinking may ... stronger gene of this type will tend to drink alcohol ... The gene is responsible for enhancing the pleasure that is ...
Cached Medicine News:
(Date:7/27/2015)... Mass. , July 27, 2015 ... of Merck KGaA of Darmstadt, ... with celares GmbH to provide pegylation services to ... service offering enabled by the collaboration includes feasibility ... milligram to gram quantities required for pilot and ...
(Date:7/27/2015)... , July 27, 2015  Endo International plc (NASDAQ: ... 2015 financial results before the open of the U.S. financial ... management team will host a conference call and webcast at ... number to access the call is U.S./ Canada ... is 93183256. Please dial in 10 minutes prior to the ...
(Date:7/27/2015)... PITTSBURGH , July 27, 2015  Mylan N.V. ... regarding Teva,s (NYSE and TASE: TEVA) announcement of its ... and its withdrawal of its unsolicited expression of interest ... Robert J. Coury stated: "We congratulate Teva on ... their continued, and potentially enhanced, commitment to the generics ...
Breaking Medicine Technology:EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH 2EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH 3Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 2Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 3Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 4Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 5Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 6Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 7Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 8Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 9
... Safety Profile of the Intramuscular Formulation,of Peramivir ... BIRMINGHAM, Ala., June 18, 2007 /PRNewswire-FirstCall/ --,BioCryst ... I,clinical studies of an intramuscular (i.m.) formulation ... of Influenza Conference in,Toronto, Ontario, Canada. This ...
... 70 abstracts highlight VELCADE efficacy in broad range,of ... Mass., June 19, 2007 /PRNewswire-FirstCall/ --,Millennium Pharmaceuticals, Inc. ... therapy with unsurpassed single-agent,efficacy for patients with previously ... upcoming International Myeloma,Workshop (IMW) in Kos, Greece, June ...
Cached Medicine Technology:BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 2BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 3BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 4BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 5BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8
... camera system for high resolution photomicrography. The ... of the highest color fidelity, resolution and ... expect perfect images due to many unique ... innovative readout modes. The Leica DFC480 is ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Stat Stain is ideal for stat, routine ... blood smears (10-15 seconds) and bone marrow ... finely dispersed stain particles which yield excellent ... many of the steps involved in the ...
Medicine Products: